ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

304
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
bullishSillaJen Inc
03 Nov 2016 11:26

SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level

* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...

Logo
257 Views
Share
01 Nov 2016 18:11

Samsung BioLogics IPO - Why Investors Are Excited & Concerned

Samsung BioLogics will have a big day tomorrow. Nov 2-3 will be the subscription day. The company has already had a huge success with the...

Logo
296 Views
Share
28 Oct 2016 06:59

Samsung BioLogics IPO Price Is Set At Highest End (₩136,000) - 3 Points to Consider

Maeil Economic Daily, Korea's largest financial newspaper, has just reported that Samsung BioLogics' IPO price was set at ₩136,000, which is the...

Logo
247 Views
Share
27 Oct 2016 13:11

Samsung BioLogics' Revised Valuation Based on P/B Multiple

In another regulatory filing, Samsung BioLogics presented a revised valuation based on P/B multiple. Obviously, there are still many people who are...

Logo
237 Views
Share
27 Oct 2016 04:46

Pass on the Deal, Put on the Watchlist

This Insight finalizes our view of the listing of Samsung BioLogics (SB) using information presented at the company’s roadshow meeting and included...

Share
x